Metoprolol: Difference between revisions
Jump to navigation
Jump to search
Gerald Chi (talk | contribs) mNo edit summary |
Gerald Chi (talk | contribs) |
||
| Line 6: | Line 6: | ||
Metoprolol is a competitive, [[Beta-1 adrenergic receptor|β<sub>1</sub>]]-selective (cardioselective) [[beta blocker|blocker]] used in treatment of [[angina pectoris]], [[hypertension]], [[arrhythmia]], and [[migraine]]. Common adverse reactions include [[bradyarrhythmia]], [[heart block]], [[heart failure]], [[hypotension]], [[pruritus]], [[rash]], [[constipation]], [[diarrhea]], [[indigestion]], [[nausea]], [[dizziness]], [[fatigue]], [[headache]], [[depression]], [[dyspnea]], and [[wheezing]]. | Metoprolol is a competitive, [[Beta-1 adrenergic receptor|β<sub>1</sub>]]-selective (cardioselective) [[beta blocker|blocker]] used in treatment of [[angina pectoris]], [[hypertension]], [[arrhythmia]], and [[migraine]]. Common adverse reactions include [[bradyarrhythmia]], [[heart block]], [[heart failure]], [[hypotension]], [[pruritus]], [[rash]], [[constipation]], [[diarrhea]], [[indigestion]], [[nausea]], [[dizziness]], [[fatigue]], [[headache]], [[depression]], [[dyspnea]], and [[wheezing]]. | ||
The active substance metoprolol is employed either as ''metoprolol [[succinic acid|succinate]]'' or as ''metoprolol [[tartrate]]'' (where 100 mg metoprolol [[tartrate]] corresponds to 95 mg metoprolol [[succinic acid|succinate]]). The [[tartrate]] is an immediate-release and the [[succinic acid|succinate]] is an extended-release [[Pharmaceutical formulation|formulation]]. | The active substance metoprolol is employed either as ''metoprolol [[succinic acid|succinate]]'' or as ''metoprolol [[tartrate]]'' (where 100 mg metoprolol [[tartrate]] corresponds to 95 mg metoprolol [[succinic acid|succinate]]). The [[tartrate]] is an immediate-release and the [[succinic acid|succinate]] is an extended-release [[Pharmaceutical formulation|formulation]]. | ||
==Category== | ==Category== | ||
Revision as of 15:09, 26 March 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Metoprolol is a competitive, β1-selective (cardioselective) blocker used in treatment of angina pectoris, hypertension, arrhythmia, and migraine. Common adverse reactions include bradyarrhythmia, heart block, heart failure, hypotension, pruritus, rash, constipation, diarrhea, indigestion, nausea, dizziness, fatigue, headache, depression, dyspnea, and wheezing.
The active substance metoprolol is employed either as metoprolol succinate or as metoprolol tartrate (where 100 mg metoprolol tartrate corresponds to 95 mg metoprolol succinate). The tartrate is an immediate-release and the succinate is an extended-release formulation.
Category
Anti-anginal, antiarrhythmic, beta-adrenergic blocker